Laval, Canada

Wilms Baille

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: **Wilms Baille: Innovator in Pharmaceutical Polymers**

Introduction

Wilms Baille, an accomplished inventor based in Laval, Canada, has made significant contributions to the field of pharmaceuticals through his innovative work on polymers. With a total of five patents to his name, Baille focuses on the development of non-ionic PVP-PLA block copolymers, which play a crucial role in enhancing the solubility of active pharmaceutical ingredients.

Latest Patents

Baille's most recent patents include revolutionary findings related to non-ionic PVP-PLA block copolymers and liquid pharmaceutical compositions derived from them. These patents discuss block copolymers defined by a specific formula, wherein the initiator alcohol has a boiling point greater than 145°C, and the copolymers have a number average molecular weight (Mn) of at least 3000 Da. This innovation provides flexibility in formulating multiple low-solubility active pharmaceutical ingredients (APIs), including flurbiprofen, celecoxib, acetaminophen, and propofol. Furthermore, the patents detail a method for synthesizing these block copolymers, which involves the polymerization of D,L-Lactide and the use of controlled polymerization techniques.

Career Highlights

Throughout his career, Wilms Baille has contributed to advancing pharmaceutical technology while working with notable companies like Zoetis Services LLC and Altus Formulation Inc. His tenure at these firms has enabled him to apply his groundbreaking research directly to the market, resulting in practical applications of his patented technologies.

Collaborations

Baille has also collaborated with esteemed professionals in the industry, such as Piotr Kujawa and Sumitra Rajagopalan. These collaborations have further enriched his patented innovations and allowed for shared expertise that enhances the overall quality and impact of his work.

Conclusion

With five patents and a focus on non-ionic PVP-PLA block copolymers, Wilms Baille's inventive work stands at the forefront of pharmaceutical advancements. His contributions not only enhance the solubility and delivery of vital medications but also pave the way for future innovations in the field. Baille’s ongoing research and collaborations promise to yield further advancements in the pharmaceutical industry, ultimately benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…